trending Market Intelligence /marketintelligence/en/news-insights/trending/h0awwvKBunZrOVXdy41hlg2 content esgSubNav
In This List

US FDA approves CYBERDYNE's lower limb medical device

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


US FDA approves CYBERDYNE's lower limb medical device

The U.S. Food and Drug Administration approved CYBERDYNE Inc.'s hybrid assistive limb medical device.

The Hybrid assistive limb device is meant for people who have lower limb disorders or those whose legs are weakening.